AGMB · AgomAb Therapeutics NV · Analyst Estimates
Market Cap
$413.68M
Shares
49.25M
Volume · Oct 27
89.8K
Avg daily vol (3M)
136.23K
Analyst Estimates
Compare analyst forecasts for AgomAb Therapeutics NV across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-10-23 14:53 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-2.08
|
-1.81
|
-1.58
|
6
|
-1.83
|
-1.85
|
-1.81
|
-1.81
|
1
|
2
|
2
|
0
|
|
Revenue
EUR
Publication date not stated |
0.00
|
0.00
|
0.00
|
6
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-2.47
|
-2.03
|
-1.46
|
6
|
-2.05
|
-2.07
|
-1.97
|
-2.00
|
0
|
1
|
2
|
0
|
|
Revenue
EUR
Publication date not stated |
0.00
|
0.00
|
0.00
|
6
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.41
|
-0.37
|
-0.33
|
3
|
-0.37
|
-0.37
|
-0.37
|
-0.48
|
0
|
0
|
1
|
1
|
|
Revenue
EUR
Publication date not stated |
0.00
|
0.00
|
0.00
|
4
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.46
|
-0.42
|
-0.35
|
3
|
-0.42
|
-0.43
|
-0.43
|
-0.54
|
0
|
0
|
1
|
1
|
|
Revenue
EUR
Publication date not stated |
0.00
|
0.00
|
0.00
|
4
|
— | — | — | — | — | — | — | — |